Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy

Endocrinology

Volumn 145, Issue 8, 2004, Pages 3858-3865

  Martínez, Alfredo ^a   Julián, Miguel ^d   Bregonzio, Claudia ^b   Notari, Luigi ^c   Moody, Terry W ^a   Cuttitta, Frank ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d Department of Chemical Sciences   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; GASTRIN RELEASING PEPTIDE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VASOACTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG SCREENING; HORMONE BINDING; HUMAN; HUMAN CELL; HYPERTENSION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SCREENING; SECOND MESSENGER; SURFACE PLASMON RESONANCE; VASOCONSTRICTION; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; ANTIBODIES, MONOCLONAL; CALCIUM; GASTRIN-RELEASING PEPTIDE; HUMANS; MALE; PEPTIDES; RATS; RATS, INBRED LEW; RATS, INBRED SHR;

EID: 3843069804     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1251     Document Type: Article

References (33)

1. López J, Martínez A 2002 Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 221:1-92
2. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
3. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM 2000 CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 275:31438-31443
4. Dobrzynski E, Wang C, Chao J, Chao L 2000 Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 36:995-1001
5. Shindo T, Kurihara H, Maemura K, Kurihara Y, Izumida T, Minamino N, Ju KH, Morita H, Oh-hashi Y, Kumada M, Kangawa K, Nagai R, Yazaki Y 2000 Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 101: 2309-2316
6. Serrano J, Alonso D, Encinas JM, López JC, Fernández AP, Castro-Blanco S, Fernández-Vizarra P, Richart A, Bentura ML, Santacana M, Uttenthal LO, Cuttitta F, Rodrigo J, Martínez A 2002 Adrenomedullin expression is upregulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience 109:717-731
7. Martínez A, Elsasser T, Bhathena SJ, Pío R, Buchanan TA, Macri CJ, Cuttitta F 1999 Is adrenomedullin a causal agent in some cases of type 2 diabetes? Peptides 20:1471-1478
8. Martínez A, Vos M, Guédez L, Kaur G, Chen Z, Garayoa M, Pío R, Moody T, Stetler-Stevenson WG, Kleinman HK, Cuttitta F 2002 The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 94:1226-1237
9. Miller MJ, Martínez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, Cuttitta F 1996 Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 271:23345-23351
10. Champion HC, Friedman DE, Lambert DG, Murphy WA, Coy DH, Kadowitz PJ 1997 Adrenomedullin(16-31) has pressor activity in the rat but not the cat. Peptides 18:133-136
11. Kitamura K, Matsui E, Kato J, Katoh F, Kita T, Tsuji T, Kangawa K, Eto T 2001 Adrenomedullin(11-26): a novel endogenous peptide isolated from bovine adrenal medulla. Peptides 22:1713-1718
12. Schultz PG, Yin J, Lerner RA 2002 The chemistry of the antibody molecule. Angew Chem Int 23:4427-4437
13. Voigt JH, Bienfait B, Wang S, Nicklaus MC 2001 Comparison of the NCI open database with seven large chemical structural databases. J Chem Inf Comput Sci 41:702-712
14. Martínez A, Weaver C, López J, Bhathena SJ, Elsasser TH, Miller MJ, Moody TW, Unsworth EJ, Cuttitta F 1996 Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 137:2626-2632
15. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD 1985 Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823-826
16. Kasprzyk PG, Cuttitta F, Avis I, Nakanishi Y, Treston A, Wong H, Walsh JH, Mulshine JL1988 Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation. Anal Biochem 174:224-234
17. Coppock HA, Owji AA, Austin C, Upton PD, Jackson ML, Gardiner JV, Ghatei MA, Bloom SR, Smith DM 1999 Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity. Biochem J 338:15-22
18. Pío R, Martínez A, Unsworth EJ, Kowalak JA, Bengoechea JA, Zipfel PF, Elsasser TH, Cuttitta F 2001 Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 276:12292-12300
19. Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR 2003 CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br J Pharmacol 140:477-486
20. Moody TW, Zia F, Venugopal R, Fagarasan M, Oie H, Hu V 1996 GRP receptors are present in non small cell lung cancer cells. J Cell Biochem Suppl 24:247-256
21. Ryan RR, Weber HC, Hou W, Sainz E, Mantey SA, Battey JF, Coy DH, Jensen RT1998 Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3. J Biol Chem 273:13613-13624
22. Martínez A, Elsasser TH, Muro-Cacho C, Moody TW, Miller MJ, Macri CJ, Cuttitta F1997 Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology 138:5597-5604
23. McDonald TJ, Jornvall H, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V1979 Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 90:227-237
24. Anastasi A, Erspamer V, Bucci M 1971 Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27:166-167
25. Merali Z, McIntosh J, Anisman H 1999 Role of bombesin-related peptides in the control of food intake. Neuropeptides 33:376-386
26. Emanuel RL, Torday JS, Mu Q, Asokananthan N, Sikorski KA, Sunday ME 1999 Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation. Am J Physiol 277:L1003-L1017
27. Shumyatsky GP, Tsvetkov E, Malleret G, Vronskaya S, Hatton M, Hampton L, Battey JF, Dulac C, Kandel ER, Bolshakov VY 2002 Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 111:905-918
28. Chaudhry A, Carrasquillo JA, Avis I, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE, Mulshine JL 1999 Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res 5:3385-3393
29. Martínez A, Pío R, López J, Cuttitta F 2001 Expression of the adrenomedullin binding protein, complement factor H, in the pancreas and its physiological impact on insulin secretion. J Endocrinol 170:503-511
30. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, Brunner N, Martin PM 2002 Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 160:1279-1292
31. Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, LeClerc S, Meijer L, Kim SH, Lockhart DJ, Schultz PG 1998 Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281:533-538
32. Ghosh S, Liu XP, Zheng Y, Uckun FM 2001 Rational design of potent and selective EGFR tyrosine kinase inhibitors as anticancer agents. Curr Cancer Drug Targets 1:129-140
33. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM 2002 International Union of Pharmacology. XXXI. The mammalian cakitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233-246